These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 21672519)
1. Electrostatic potential as a tool to understand interactions between malaria vaccine candidate peptides and MHC II molecules. Agudelo WA; Galindo JF; Patarroyo ME Biochem Biophys Res Commun; 2011 Jul; 410(3):410-5. PubMed ID: 21672519 [TBL] [Abstract][Full Text] [Related]
2. High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion. Patarroyo ME; Bermúdez A; Salazar LM; Espejo F Biochimie; 2006 Jul; 88(7):775-84. PubMed ID: 16483708 [TBL] [Abstract][Full Text] [Related]
3. Changing ABRA protein peptide to fit into the HLA-DRbeta1*0301 molecule renders it protection-inducing. Salazar LM; Alba MP; Curtidor H; Bermúdez A; Luis E Vargas ; Rivera ZJ; Patarroyo ME Biochem Biophys Res Commun; 2004 Sep; 322(1):119-25. PubMed ID: 15313182 [TBL] [Abstract][Full Text] [Related]
4. Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex. Patarroyo ME; Salazar LM; Cifuentes G; Lozano JM; Delgado G; Rivera Z; Rosas J; Vargas LE Biochimie; 2006 Feb; 88(2):219-30. PubMed ID: 16126320 [TBL] [Abstract][Full Text] [Related]
6. Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register. Patarroyo ME; Alba MP; Vargas LE; Silva Y; Rosas J; Rodríguez R Biochemistry; 2005 May; 44(18):6745-54. PubMed ID: 15865420 [TBL] [Abstract][Full Text] [Related]
7. Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine. Patarroyo ME; Cifuentes G; Rodríguez R Int J Biochem Cell Biol; 2008; 40(3):543-57. PubMed ID: 17997122 [TBL] [Abstract][Full Text] [Related]
8. Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine. Bermúdez A; Vanegas M; Patarroyo ME Vaccine; 2008 Dec; 26(52):6908-18. PubMed ID: 18930095 [TBL] [Abstract][Full Text] [Related]
9. Quantum chemical analysis explains hemagglutinin peptide-MHC Class II molecule HLA-DRbeta1*0101 interactions. Cárdenas C; Villaveces JL; Bohórquez H; Llanos E; Suárez C; Obregón M; Patarroyo ME Biochem Biophys Res Commun; 2004 Oct; 323(4):1265-77. PubMed ID: 15451434 [TBL] [Abstract][Full Text] [Related]
10. Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria. Cifuentes G; Espejo F; Vargas LE; Parra C; Vanegas M; Patarroyo ME Biochemistry; 2004 Jun; 43(21):6545-53. PubMed ID: 15157087 [TBL] [Abstract][Full Text] [Related]
11. The role of amino acid electron-donor/acceptor atoms in host-cell binding peptides is associated with their 3D structure and HLA-binding capacity in sterile malarial immunity induction. Patarroyo ME; Almonacid H; Moreno-Vranich A Biochem Biophys Res Commun; 2012 Jan; 417(3):938-44. PubMed ID: 22197813 [TBL] [Abstract][Full Text] [Related]
12. Fitting modified HRP-I peptide analogue 3D structure into HLA-DR molecules induces protection against Plasmodium falciparum malaria. Bermúdez A; Alba P; Espejo F; Vargas LE; Parra C; Rodríguez R; Reyes C; Patarroyo ME Int J Biochem Cell Biol; 2005 Feb; 37(2):336-49. PubMed ID: 15474979 [TBL] [Abstract][Full Text] [Related]
13. Modifying RESA protein peptide 6671 to fit into HLA-DRbeta1* pockets induces protection against malaria. Alba MP; Salazar LM; Vargas LE; Trujillo M; Lopez Y; Patarroyo ME Biochem Biophys Res Commun; 2004 Mar; 315(4):1154-64. PubMed ID: 14985134 [TBL] [Abstract][Full Text] [Related]
14. Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins. Cifuentes G; Vanegas M; Martinez NL; Pirajan C; Patarroyo ME Biochem Biophys Res Commun; 2009 Jul; 384(4):455-60. PubMed ID: 19422790 [TBL] [Abstract][Full Text] [Related]
15. Comparative molecular and three-dimensional analysis of the peptide-MHC II binding region in both human and Aotus MHC-DRB molecules confirms their usefulness in antimalarial vaccine development. Patarroyo ME; Cifuentes G; Baquero J Immunogenetics; 2006 Jul; 58(7):598-606. PubMed ID: 16791622 [TBL] [Abstract][Full Text] [Related]
17. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705. Jones MA; Hislop AD; Snaith JS Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283 [TBL] [Abstract][Full Text] [Related]
19. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a reduced peptide bond analogue of a promiscuous CD4 T cell epitope derived from the Plasmodium falciparum malaria vaccine candidate merozoite surface protein 1. Bastian M; Lozano JM; Patarroyo ME; Pluschke G; Daubenberger CA Mol Immunol; 2004 Jul; 41(8):775-84. PubMed ID: 15234557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]